Latest Financial Disclosure News

Page 4 of 18
Thorney Technologies Limited (ASX, TEK) will resume trading on the ASX from 16 December 2025 following the lodgement of its Net Tangible Asset Backing, ending its recent suspension.
Sophie Babbage
Sophie Babbage
16 Dec 2025
AMP has reached an agreement in principle to settle a long-running class action over commissions paid between 2014 and 2021, agreeing to pay $29 million without admitting liability.
Claire Turing
Claire Turing
11 Dec 2025
Moonlight Resources Limited is set to raise A$10 million through a fully underwritten IPO, targeting exploration and development of its diverse mineral projects across Australia. The offer includes 50 million shares priced at $0.20 each, with free options attached.
Maxwell Dee
Maxwell Dee
9 Dec 2025
Novatti Group’s investment in AUDC Pty Ltd, issuer of the AUDD stablecoin, has nearly doubled in value following a $5 million Pre-Series A funding round led by a major global institutional investor.
Claire Turing
Claire Turing
8 Dec 2025
The Federal Court of Australia has approved BHP’s AU$110 million settlement of the Samarco shareholder class action, marking a significant legal milestone for the mining giant.
Maxwell Dee
Maxwell Dee
5 Dec 2025
Anteris Technologies has secured regulatory green lights for its pivotal PARADIGM trial and raised $25.2 million in capital, advancing its innovative DurAVR® transcatheter heart valve towards commercialisation.
Ada Torres
Ada Torres
4 Dec 2025
Brightstar Resources has completed its merger with Aurumin Limited, acquiring all shares and issuing new Brightstar shares and options to Aurumin security holders on a 1-for-4 basis.
Maxwell Dee
Maxwell Dee
2 Dec 2025
SDI Limited reported stable FY25 revenue with improved margins and advancing Montrose project, while regional sales showed mixed results.
Ada Torres
Ada Torres
27 Nov 2025
Electro Optic Systems has resolved ASIC's investigation into its 2022 revenue guidance breaches by agreeing to a $4 million penalty, paving the way for renewed focus on growth and governance.
Victor Sage
Victor Sage
26 Nov 2025
Mesoblast Limited forecasts a significant jump in quarterly revenue, driven by strong sales of its FDA-approved cell therapy Ryoncil. The company’s latest update highlights robust growth and ongoing expansion in inflammatory disease treatments.
Ada Torres
Ada Torres
25 Nov 2025
Elanor Investors Group has extended deadlines for a $125 million investment from Rockworth Capital Partners and the acquisition of Firmus, with a key shareholder meeting now scheduled for late January 2026.
Eva Park
Eva Park
24 Nov 2025
Metro Performance Glass reported a surprising 157% jump in net profit for H1 2025, even as revenue fell 5%, raising questions about underlying business dynamics.
Victor Sage
Victor Sage
24 Nov 2025